Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,951 public trials 2,018 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12)

NCT07059650

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Peking University Third Hospital Beijing, China

Hunan Cancer Hospital Changsha, China

West China Hospital of Sichuan University Chengdu, China

Guangdong Provincial People's Hospital Guangzhou, China

View all 13 locations

View Trial Details

Recruiting

Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma

NCT07030400

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +15 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Recruiting

Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL

NCT07234487

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: A.N.Bakulev Center for cardiovascular surgery of the Russian Ministry of Health Moscow, Russia

National Medical and Surgical Center named after N.I. Pirogov Moscow, Russia

St. Petersburg State Pavlov Medical University Saint Petersburg, Russia

View Trial Details

Recruiting

Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL

NCT06104592

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Recruiting

Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

NCT06144606

Conditions: Acute Lymphoblastic Leukemia, B-Cell Lymphoblastic Leukemia, Burkitt Lymphoma, +20 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Recruiting

Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy

NCT05757219

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Recruiting

Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma

NCT07300514

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoblastic Lymphadenopathy, +11 more
Locations: Fudan University Shanghai Cancer Center Shanghai, China

View Trial Details

Recruiting

Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL

NCT06553872

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Stanford Cancer Center Stanford, California, United States

Univ of Miami - Sylvester Comprehensive Cancer Center Miami, Florida, United States

Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Recruiting

Hematopoiesis in MBL and CLL Versus Healthy Age-Matched Control Subjects

NCT06536452

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant

NCT06687772

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions